Paper41228343
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.
Fasano M and 20 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer. Papers, record 41228343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41228343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23026829 | Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/23026829 | PubMed |
| 2 | 30828911 | Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab. | Head Neck | 2019 | https://conductscience.org/library/papers/30828911 | PubMed |
| 3 | 16012181 | Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. | Ann Oncol | 2005 | https://conductscience.org/library/papers/16012181 | PubMed |
| 4 | 20530316 | Human papillomavirus and survival of patients with oropharyngeal cancer. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20530316 | PubMed |
| 5 | 33150521 | Prospective practice survey of management of cetuximab-related skin reactions. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/33150521 | PubMed |
| 6 | 19289626 | Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19289626 | PubMed |
| 7 | 12506176 | An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12506176 | PubMed |
| 8 | 18559875 | Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18559875 | PubMed |
| 9 | 31015170 | The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis. | Radiother Oncol | 2019 | https://conductscience.org/library/papers/31015170 | PubMed |
| 10 | 19446902 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. | Radiother Oncol | 2009 | https://conductscience.org/library/papers/19446902 | PubMed |
| 11 | 19699545 | Oral cavity squamous cell carcinoma in 260 patients aged 80years or more. | Radiother Oncol | 2009 | https://conductscience.org/library/papers/19699545 | PubMed |
| 12 | 19524312 | Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer. | Radiother Oncol | 2009 | https://conductscience.org/library/papers/19524312 | PubMed |
| 13 | 22194030 | Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. | Strahlenther Onkol | 2012 | https://conductscience.org/library/papers/22194030 | PubMed |
| 14 | 34098030 | Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study. | Int J Radiat Oncol Biol Phys | 2021 | https://conductscience.org/library/papers/34098030 | PubMed |
| 15 | 21110844 | Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience. | Head Neck Oncol | 2010 | https://conductscience.org/library/papers/21110844 | PubMed |
| 16 | 31242489 | Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study. | Chemotherapy | 2019 | https://conductscience.org/library/papers/31242489 | PubMed |
| 17 | 14722034 | Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14722034 | PubMed |
| 18 | 22250183 | Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. | Ann Oncol | 2012 | https://conductscience.org/library/papers/22250183 | PubMed |
| 19 | 27212198 | Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience. | Int J Radiat Oncol Biol Phys | 2016 | https://conductscience.org/library/papers/27212198 | PubMed |
| 20 | 26553007 | G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26553007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41228343
GET https://conductscience.org/api/papers/v1/41228343/authors?page=2